lifestyle.celebhomes.net
Home
Sample Page
Author:
IRLAB Therapeutics
IRLAB: Invitation to the Interim Report for Q1 2026 Presentation and Webcast
April 30, 2026
IRLAB publishes the Annual Report for 2025
April 29, 2026
Nomination Committee’s proposal to the Board of Directors for IRLAB Therapeutics’ Annual General Meeting 2026
April 17, 2026
IRLAB to Present at Redeye Healthcare Day 2026
April 9, 2026
IRLAB to Present Clinical and Preclinical Data at The AD/PD(TM) 2026 – 20th International Conference on Alzheimer’s & Parkinson’s Diseases
March 17, 2026
IRLAB Enters Collaboration Agreement with Danish Biotech Company Biomia ApS Applying the Integrative Screening Process (ISP)
January 19, 2026
IRLAB Receives Approval for a Phase Ib Study with IRL757 in Parkinson’s Disease
December 23, 2025
The European Patent Office Intends to Grant a New Patent for IRLAB’s Mesdopetam
December 12, 2025